BioSpace News Archive

FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) today announced the launch of a pilot clinical study in Pittsburgh, Pennsylvania, by its strategic R&D partner, SciCann Therapeutics (“SciCann”).

CANbridge Pharmaceutical Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced that it was named one of four Deputy Director Generals at the inaugural meeting of the China Alliance for Rare Disease

Genome Medical, a leading telegenomics technology and services company, announced today that it has begun providing genetic counseling services for Cigna customers and contracted health care providers, effective Oct. 1.

Aflac Chairman and CEO Dan Amos, the second longest tenured CEO in the Fortune 200 and four-time recipient of the Harvard Business Review’s recognition as one of the 100 Best-Performing CEOs in the World, recently sat down at the company’s headquarters in Columbus, Georgia, for an interview with 11-year-old cancer survivor Chloe Davison of Grants Pass, Oregon.

New Fibroblast survey reveals disconnect between how leaders perceive vs. act on patient leakage

Walgreens Adds Florajen to “Ask Your Pharmacist” Section Nationwide

Essential are experts in user-centred design, improving customer experiences and driving innovation to market.

Physicians, chief information officers, and leaders in the MEDITECH community gathered to discuss how leveraging EHR technologies and building new relationships go hand-in-hand with their quality improvement initiatives.

As the author of a book on managing fear, Stan struggled with fear, anxiety, and worry for over 20 years.

Stellar Biotechnologies, Inc. announced today that Stellar President and CEO Frank R. Oakes will present at the 10th Annual BlueTech Summit to be held November 5-9, 2018 in San Diego, California.